Luteinizing Hormone–Releasing Hormone Agonist Triptorelin and Antagonist Cetrorelix Inhibit EGF-Induced c-fos Expression in Human Gynecological Cancers

This publication has 26 references indexed in Scilit:

• Presence and characteristics of receptors for [D-Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer.
  International Journal of Oncology, 1998
• Growth-inhibitory actions of analogues of Luteinizing Hormone Releasing Hormone on tumor cells.
  Trends in Endocrinology & Metabolism, 1997
• The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary
  Molecular and Cellular Endocrinology, 1994
• Presence of Gonadotropin-Releasing Hormone Receptor and Its Messenger Ribonucleic Acid in Endometrial Carcinoma and Endometrium
  Gynecologic Oncology, 1994
• Inhibition of human epithelial ovarian cancer cellgrowth in vitro by agonistic and antagonistic analogues of luteinizinghormone-releasing hormone.
  Proceedings of the National Academy of Sciences, 1994
• Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma
  American Journal of Obstetrics and Gynecology, 1993
• Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters
  Breast Cancer Research and Treatment, 1993
• Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata
  European Journal of Cancer and Clinical Oncology, 1989
• Characteristics and distribution of receptors for [d‐trp⁶]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
  Journal of Clinical Laboratory Analysis, 1989
• Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*
  Journal of Clinical Endocrinology & Metabolism, 1987